Blood antioxidant status, dysglycemia and obstructive sleep apnea

Advances in Experimental Medicine and Biology

Volumn 756, Issue , 2013, Pages 121-129

  Wysocka, Ewa ^a   Cofta, Szczepan ^a   Piorunek, Tomasz ^a   Dziegielewska Gesiak, Sylwia ^a   Bryl, Wieslaw ^a   Torlinski, Lech ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Antioxidant status; Cardiovascular morbidity; Obesity; Obstructive sleep apnea; Oral glucose tolerance; Oxidative stress; Prediabetes

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL;

ADULT; BIOCHEMICAL COMPOSITION; BLOOD SAMPLING; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; CONTROLLED STUDY; DYSGLYCEMIA; ENZYME BLOOD LEVEL; ERYTHROCYTE LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; POLYSOMNOGRAPHY; PRIORITY JOURNAL; SLEEP DISORDERED BREATHING; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84867559405     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-94-007-4549-0_16     Document Type: Conference Paper

References (29)

1. Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C., Jr. (2009). Harmonizing the metabolic syndrome: A join interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation, 120 , 1640-1645.
2. American Diabetes Association. (2011). The expert committee on the diagnosis and classi fi cation of diabetes: Diagnosis and classi fi cation of diabetes mellitus. Diabetes Care, 34 , S62-S69.
3. Barceló, A., Barbé, F., de la Pe?a, M., Vila, M., Pérez, G., Piérola, J., Durán, J., & Agustí, A. G. (2006). Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment. European Respiratory Journal, 27 , 756-760.
4. Ceriello, A., & Motz, E. (2004). Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arteriosclerosis, Thrombosis, and Vascular Biology, 24 , 816-823.
5. Dorkova, Z., Petrasova, D., Molcanyiova, A., Popovnakova, M., & Tkacova, R. (2008). Effects of continuous positive airway pressure on cardiovascular risk pro fi le in patients with severe obstructive sleep apnea and metabolic syndrome. Chest, 134 , 686-692.
6. Edge, D., Skelly, J. R., Bradford, A., & O'Halloran, K. D. (2010). Respiratory plasticity in the behaving rat following chronic intermittent hypoxia. Advances in Experimental Medicine and Biology, 669 , 267-270.
7. Habdous, M., Herbeth, B., Vincent-Viry, M., Lamont, J. V., Fitzgerald, P. S., Visvikis, S., & Siest, G. (2003). Serum total antioxidant status, erythrocyte superoxide dismutase and whole-blood glutathione peroxidase activities in the Stanislas cohort: In fluencing factors and reference intervals. Clinical Chemistry and Laboratory Medicine, 41 , 209-215.
8. Kiely, J. L., & McNicholas, W. T. (2000). Cardiovascular risk factors in patients with obstructive sleep apnoea syndrome. European Respiratory Journal, 16 , 128-133.
9. Lavie, L. (2003). Obstructive sleep apnoea syndrome-an oxidative stress disorder. Sleep Medicine Reviews, 7 , 35-51.
10. Lavie, L., & Lavie, P. (2009). Molecular mechanisms of cardiovascular disease in OSAHS: The oxidative stress link. European Respiratory Journal, 33 , 1467-1484.
11. Lévy, P., Bonsignore, M. R., & Eckel, J. (2009). Sleep, sleep-disordered breathing and metabolic consequences. European Respiratory Journal, 34 , 243-260.
12. McNicholas, W. T., Bonsignore, M. R., & The Management Committee of the COST Action B26. (2007). Sleep apnoea as an independent risk factor for cardiovascular disease: Current evidence, basic mechanisms and research priorities. European Respiratory Journal, 29 , 156-178.
13. Okhawa, H., Ohishi, N., & Yagi, K. (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry, 95 , 351-358.
14. Peker, Y., Hedner, J., Norum, J., Kraiczi, H., & Carlson, J. (2002). Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: A 7-year follow up. American Journal of Respiratory and Critical Care Medicine, 166 , 159-165.
15. Peppard, P. E., Young, T., Palta, M., & Skatrud, J. (2000). Prospective study of the association between sleep-disordered breathing and hypertension. The New England Journal of Medicine, 342 , 1378-1384.
16. Punjabi, N. M. (2008). The epidemiology of adult obstructive sleep apnea. Proceedings of the American Thoracic Society, 5 , 136-143.
17. Punjabi, N. M., Shahar, E., Redline, S., Gottlieb, D. J., Givelber, R., Resnick, H. E., & Sleep Heart Health Study Investigators. (2004). Sleep-disordered breathing, glucose intolerance, and insulin resistance: The Sleep Heart Health Study. American Journal of Epidemiology, 160 , 521-530.
18. Rabbani, N., Chittari, M. V., Bodmer, C. W., Zehnder, D., Ceriello, A., & Thornalley, P. J. (2010). Increased glycation and oxidative damage to apolipoprotein B100 of LDL cholesterol in patients with type 2 diabetes and effect of metformin. Diabetes, 59 , 1038-1045.
19. Raport of a WHO Study Group. (1994). Prevention of diabetes mellitus . WHO Technical Report Series, Vol. 844. Geneva: World Health Organization.
20. Rasche, K., Keller, T., Tautz, B., Hader, C., Hergenc, G., Antosiewicz, J., Di Giulio, C., & Pokorski, M. (2010). Obstructive sleep apnea and type 2 diabetes. European Journal of Medical Research, 15 (Suppl. II), 152-156.
21. Schulz, R., Mahmoudi, S., Hattar, K., Sibelius, U., Olschewski, H., Mayer, K., Seeger, W., & Grimminger, F. (2000). Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. American Journal of Respiratory and Critical Care Medicine, 162 , 566-570.
22. Shahar, E., Whitney, C. W., Redline, S., Lee, E. T., Newman, A. B., Javier Nieto, F., O'Connor, G. T., Boland, L. L., Schwartz, J. E., & Samet, J. M. (2001). Sleep-disordered breathing and cardiovascular disease: Cross sectional results of the Sleep Heart Health Study. American Journal of Respiratory and Critical Care Medicine, 163 , 19-25.
23. Shaw, J. E., Punjabi, N. M., Wilding, J. P., Alberti, K. G., Zimmet, P. Z., & International Diabetes Federation Taskforce on Epidemiology and Prevention. (2008). Sleep-disordered breathing and type 2 diabetes: A report from the International Diabetes Federation Taskforce on Epidemiology and Prevention. Diabetes Research and Clinical Practice, 81 , 2-12.
24. Song, F., Jia, W., Yao, Y., Hu, Y., Lei, L., Lin, J., Sun, X., & Liu, L. (2007). Oxidative stress, antioxidant status and DNA damage in patients with impaired glucose regulation and newly diagnosed type 2 diabetes. Clinical Science, 112 , 599-606.
25. Tamura, A., Kawano, Y., Watanabe, T., & Kadota, J. (2008). Relationship between the severity of obstructive sleep apnea and impaired glucose metabolism in patients with obstructive sleep apnea. Respiratory Medicine, 102 , 1412-1416.
26. Tasali, E., Mokhlesi, B., & Van Cauter, E. (2008). Obstructive sleep apnea and type 2 diabetes: Interacting epidemics. Chest, 133 , 496-506.
27. Theorell-Haglöw, J., Berne, C., Janson, C., & Lindberg, E. (2008). Obstructive sleep apnoea is associated with decreased insulin sensitivity in females. European Respiratory Journal, 31 , 1054-1060.
28. Wysocka, E., Cofta, S., Cymerys, M., Gozdzik, J., Torlinski, L., & Batura-Gabryel, H. (2008). The impact of the sleep apnea syndrome on oxidant-antioxidant balance in the blood of overweight and obese patients. Journal of Physiology and Pharmacology, 59 (Suppl 6), 761-769.
29. Yaggi, H. K., Concato, J., Kernan, W. N., Lichtman, J. H., Brass, L. M., & Mohsenin, V. (2005). Obstructive sleep apnea as a risk factor for stroke and death. The New England Journal of Medicine, 353 , 2034-2041.